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Abstract
Voltage-gated potassium channels that activate near the neuronal resting membrane potential are important regulators of
excitation in the nervous system, but their functional diversity is still not well understood. For instance, Kv12.2 (ELK2,
KCNH3) channels are highly expressed in the cerebral cortex and hippocampus, and although they are most likely to
contribute to resting potassium conductance, surprisingly little is known about their function or regulation. Here we
demonstrate that the auxiliary MinK (KCNE1) and MiRP2 (KCNE3) proteins are important regulators of Kv12.2 channel
function. Reduction of endogenous KCNE1 or KCNE3 expression by siRNA silencing, significantly increased macroscopic
Kv12.2 currents in Xenopus oocytes by around 4-fold. Interestingly, an almost 9-fold increase in Kv12.2 currents was
observed with the dual injection of KCNE1 and KCNE3 siRNA, suggesting an additive effect. Consistent with these findings,
over-expression of KCNE1 and/or KCNE3 suppressed Kv12.2 currents. Membrane surface biotinylation assays showed that
surface expression of Kv12.2 was significantly increased by KCNE1 and KCNE3 siRNA, whereas total protein expression of
Kv12.2 was not affected. KCNE1 and KCNE3 siRNA shifted the voltages for half-maximal activation to more hyperpolarized
voltages, indicating that KCNE1 and KCNE3 may also inhibit activation gating of Kv12.2. Native co-immunoprecipitation
assays from mouse brain membranes imply that KCNE1 and KCNE3 interact with Kv12.2 simultaneously in vivo, suggesting
the existence of novel KCNE1-KCNE3-Kv12.2 channel tripartite complexes. Together these data indicate that KCNE1 and
KCNE3 interact directly with Kv12.2 channels to regulate channel membrane trafficking.
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Introduction
Neuronal voltage-gated (Kv) potassium channels that open at
membrane potentials close to the threshold for action potential
generation have a profound effect on neuronal excitability because
of their ability to stabilize membrane potentials below the
threshold for action potential initiation. Kv12 (Elk) channels are
among the most interesting sub-threshold Kv channels because
they activate at more hyperpolarized potentials than other
outwardly rectifying Kv channels [1–5], suggesting a strong
influence on the resting membrane potential. Three distinct
mammalian Kv12 channel genes have been identified: Kv12.1,
Kv12.2 and Kv12.3 [1,2,6]; all three are primarily expressed in
the brain [2,5,7,8]. However, in situ hybridization and real time
RT-PCR studies have revealed that Kv12.2 is the most abundant,
with high expression evident in the dentate gyrus, hippocampal
pyramidal neurons, cortex, cerebellum and basal ganglia [5,8].
Interestingly these regions of the brain have been associated with
pathophysiological hyperexcitability; disruption of K
+ currents in
the dentate gyrus can lead to abnormal hippocampal synchroni-
zation and temporal lobe seizures [9]. However, despite the strong
potential for Kv12 family K
+ channels as important regulators of
neuronal function and cellular excitability, the cellular neurophys-
iology, fundamental regulation mechanisms and molecular
composition of these channels remains unknown.
We reasoned that we could gain insights into the regulation and
molecular composition of Kv12 channels by identifying interacting
proteins. Interestingly, previous studies have demonstrated that the
single transmembrane domain b-subunits MinK and MinK-
related peptides (MiRPs), which are encoded by the KCNE genes,
modify and often radically alter gating, conductance and the
pharmacology of a diverse range of Kv channels [10]. For example
KCNE b-subunits alter KCNQ, ERG, and HCN channel
currents, as well as members of the Kv1-4 channel family [11–
17]. As Kv12.2 channels are closely related to ERG channels
[5,18], we hypothesized that endogenous KCNE genes similarly
regulate Kv12.2 channel function.
Historically the role of KCNE genes in Kv channel regulation
has primarily focused on mammalian heart; with more recent
studies focusing on the gastrointestinal tract and skeletal muscle
[15,19–23]. To date five known members of the KCNE gene
family have been identified (KCNE1-5), and all have been shown
to effect Kv channels in vitro [10].These accessory proteins provide
an important mechanism for achieving functional diversity among
potassium channels. For example, KCNE1 subunits co-assemble
with KCNQ1 Kv channels to generate the IKs current in human
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hERG to form the cardiac IKr current [20]. KCNE3 has been
proposed to regulate Kv3.4 a-subunits in skeletal muscle, reducing
after hyperpolarizations [19]. However despite the mRNA
expression of all identified KCNE genes (KCNE1-5) in mamma-
lian brain [10,13,26,27], surprisingly few studies have investigated
their possible role in K
+ channel regulation in the brain.
Furthermore the possibility of the KCNE peptides regulating the
sub-threshold Kv12 channels has never been addressed.
Here we firstly demonstrate that KCNE1 and KCNE3 regulate
the membrane surface expression of Kv12.2 in vitro. Furthermore,
native co-immunoprecitiation studies revealed that KCNE1 and
KCNE3 interact simultaneously with Kv12.2 channels in vivo. This
novel finding suggests that Kv12.2 channel surface expression and
activity may be regulated by the formation of tripartite complexes
with KCNE1 and KCNE3; thus we describe a novel role for these
regulatory b subunits in the brain.
Materials and Methods
Ethics Statement
Mice were housed at the ICND vivarium at The Scripps
Research Institute. Procedures for procurement of animals,
conditioning/quarantine, housing, management, veterinary care,
and disposal of carcasses were reviewed by veterinary staff and
follow guidelines set down by the NIH Guide for Care and Use of
Laboratory Animals.
Molecular biology and Xenopus oocyte preparation
Full length mouse KCNE1 (mKCNE1), mKCNE2, mKCNE3,
mKCNE4, mKCNE5 and mKv12.2 cDNAs were cloned into the
pOX vector [28] for expression in Xenopus oocytes. Capped cRNA
transcripts were prepared by run-off transcription using the T3
mMessagemMachinekit(Ambion,Austin, TX, USA). cRNAswere
cleaned by lithium chloride precipitation and diluted in RNase-free
dH2O to desired concentrations before injection. Mature Xenopus
oocytes (Nasco, CA, USA) were isolated from ovarian lobes and
defolliculated by mechanical agitation in Ca
2+-free ND96 solution
(96 mMNaCl,2 mMKCl,1 mMMgCl2,and5 mMHEPES,with
pH adjusted to 7.5 with NaOH) containing 1 mg/ml collagenase
(type II, Sigma, MO, USA). Oocytes were injected with a total of
55 nl of cRNA solution in dH2O containing mKv12.2 (,1n g ) ,
and/or mKCNE cRNAs (,50 pg) as required. For RNAi, 500 pg
of double-stranded siRNA 21-mer oligos (Invitrogen, CA) were
injected into oocytes immediately after injection of a-subunit
Kv12.2 channel cRNA (see Table 1 for sequences). Oocytes were
incubated at 18uC for 48-hours before recording in ND96 solution
(supplemented with 1.8 mM CaCl2, 100 U/ml penicillin, 100 mg/
ml streptomycin, and 2.5 mM sodium pyruvate).
RT-PCR
For assessment of RNAi gene silencing at the mRNA level,
equal numbers of oocytes were injected either with Xenopus
KCNE1 siRNA (xKCNE1), xKCNE3 siRNA, or xKCNE5.1
siRNA and compared to non-injected controls (n=6). Total RNA
was extracted using an RNeasy Mini Kit (Qiagen, CA) after 48-
hours incubation. RNA integrity was assessed by gel electropho-
resis; only RNA preparations with two clear sharp ribosomal
bands were used in subsequent experiments. First strand cDNA
was synthesized from 500 ng of each total RNA sample using
oligo-dT and SuperscriptIII reverse transcriptase (Invitrogen, CA).
Triplicate RT reactions were performed, along with an additional
reaction in which the reverse transcriptase enzyme was omitted to
allow for assessment of contamination in each sample. RT-PCR
for each gene was performed with primers listed in Table 2 using
Go Taq Hot Start polymerase (Promega, WI). The thermocycler
protocol for all PCR reactions was as follows: 94uC for 3 minutes,
96uC for 20 seconds, 53uC for 30 seconds, 72uC for 45 seconds,
and finally 74uC for 5 minutes; for a total of 35 cycles. To
normalize for mRNA concentration, RT-PCR was also performed
with Xenopus b-actin. Optical density of cDNA samples size-
fractionated on a 1% agarose gel and stained with ethidium
bromide was determined and the intensity of each cDNA product
relative to b-actin was quantified using NIH ImageJ. RT-PCR
experiments were repeated three times with separately injected
oocyte batches, yielding similar results. Mean6SEM values are
shown. For statistical analysis, Student’s t test was used to
determine significant difference between two groups and p,0.05
was considered significant.
Kv12.2 channel antibody development and
characterization
A polyclonal antibody, targeted to a highly conserved C-
terminal region of the Kv12.2 channel (residues 701–802) was
generated in rabbits. The corresponding DNA sequence was
cloned into a pGEX-4T1 vector in frame with the GST coding
sequence (Amersham, NJ). GST-Kv12.2 channel fusion proteins
were produced in BL21 bacteria (Stratagene, CA) and purified via
a glutathione agarose column (Amersham, NJ). The Kv12.2
channel was removed from the GST moiety by thrombin
digestion, and conjugated to KLH. Kv12.2-KLH conjugated
antigen was used for the initial boost, and unconjugated Kv12.2
antigen was provided for three subsequent boosts. All immuniza-
tions and bleeds were performed by QED Biosciences (CA).
Antibody specificity was rigorously tested and optimized in Kv12.2
channel transiently-transfected and non-transfected cell lines.
Briefly, CHO cells were plated at a density of ,5610
6 cells per
100 mm Petri dish, cells were washed once in ice cold PBS and
,2 ml of homogenization buffer (10 mM Tris-HCl, 320 mM
sucrose, and a protease inhibitor cocktail (Calbiochem, San Diego,
CA). was added to each Petri dish. Cells were removed with a cell
scraper and homogenized with an 18-guage needle, passing the
cell lysate through the needle 10 times on ice. Lysates were
centrifuged (10006g, 10 min), supernatants were collected on ice
and quantified by SDS-PAGE and Coomassie blue protein gel
stain (Pierce, Rockford, IL). Equal concentrations of protein were
loaded onto a 12% denaturing SDS Tris-glycine gel (Invitrogen)
and following transfer blots were probed with Kv12.2 primary
antibody using standard Western blot techniques. Antibody
validation studies with controls revealed that 1:100 dilution of
the Kv12.2 primary antibody gave the best signal to noise ratio.
Membrane surface biotinylation assays
Kv12.2 channel membrane expression was assessed by
membrane surface biotinylation assay utilizing a ‘Cell surface
protein isolation kit’ (Pierce, IL), according to instructions from the
manufacturer. Xenopus oocytes (10 per condition) were injected
Table 1. siRNA KCNE gene sequences.
Gene Bases Top Strand Sequence
KCNE1 330–350 59-GAACAAGUUUGCAGUGGAATT-39
KCNE3 286–306 59-GGGAACCACACGGACGCCATT-39
KCNE5.1 260–280 59-GGGAAUGGAAUAAGAACAATT-39
doi:10.1371/journal.pone.0006330.t001
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siRNA and/or KCNE3 siRNA. To assess levels of endogenous
channel expression, oocytes were injected with dH20 only.
48 hours post-injection oocytes were mechanically stripped of
their vitelline membranes and surface proteins were labeled with
sulfo-NHS-Biotin (Pierce, IL) for 30 minutes at 4uC; the reaction
was then quenched and the oocytes were gently washed with Tris-
buffered saline (TBS). Oocytes were lysed in 500 ml of radio-
immunoprecipitation assay (RIPA) buffer (1 mM EDTA, 20 mM
Tris, 158 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate)
supplemented with protease inhibitors, and homogenized using a
5 ml syringe with a 22-guage needle. Homogenized lysates were
then left on ice for 30 minutes and, to improve the solubilization
efficiency, were passed through a 5 ml syringe with a 27-guage
needle five further times. Lysates were centrifuged (10,0006g) for 2
minutes at 4uC, the clarified supernatant was collected and 200 ml
of each supernatant was saved to assess changes in oocyte total
protein expression. Biotin labeled proteins were isolated by
immobilization on a NeutrAvidin Gel column (Pierce, IL), and
eluted with 2 mM free D-biotin (Pierce, IL); isolated samples were
then analyzed by SDS-PAGE, transferred to nitrocellulose
membranes, and probed with primary antibodies as indicated
for one hour at room temperature. Detection was via chicken anti-
rabbit or chicken anti-mouse horseradish peroxidase-coupled
(HRP) secondary antibodies (Bio-Rad, CA) with one-hour
incubation at room temperature, and membranes were developed
with ‘Supersignal ECL’ (Pierce, IL). To assess that only the
membrane fraction of the oocytes had been successfully isolated
the endoplasmic reticulum (ER) marker calnexin (Stressgen, MI;
1:2000) was used to re-probe each blot. Finally, the cell membrane
marker integrin-b1 (1:2000) (N-20, Santa Cruz Biotechnology,
CA) was used to ensure equal protein loading. The intensity of
each band relative to the total amount of protein loaded per lane
(b-actin) or total membrane fraction (b1-intergrin) was quantified
using the ‘gel’ module in NIH ImageJ. Mean6SEM values are
shown. For statistical analysis, Student’s t test was used to
determine significant difference between two groups and p,0.05
was considered significant.
Co-immunoprecipitation of Kv12.2 channels from mouse
brain lysates
Freshly isolated adult mouse brains were homogenized using a
‘Polytron’ homogenizer (power 18) for 2610215 s pulses on ice. A
gap of 1 minute was allowed between each pulse, to ensure the
sample remained cool. The homogenate buffer was composed of
10 mM Tris-HCl (pH 7.4), containing 320 mM sucrose plus a
protease inhibitor cocktail (Calbiochem, CA). Homogenates were
centrifuged at 10006g for 10 minutes at 4uC; the supernatant was
removed and centrifuged further (100,000 g) for 30-minutes at 4uC.
The pellet was solubilized in immunoprecipitation (IP) buffer
(50 mM Tris-Cl, 20 mM MgCl2, 150 mM NaCl, 0.5% Igepal
(Sigma, CA) and a protease inhibitor cocktail (Sigma), pH 7) at 4uC
for 30 minutes (for details see Manning 1999). Anti-Kv12.2 (1:100),
KCNE1 (N-16) or KCNE3 (N-18) (both Santa Cruz Biotechnology,
CA; 1:100) or anti-Kir2.1 (Chemicon CA; 1:50) as a negative
control, covalently conjugated to 20 ml of protein A/G sepharose
beads (ProFound kit, Pierce, IL) were added to each respective
preparation, and left overnight at 4uC. Each lysate/antibody/bead
preparation was then transferred to a preconditioned spin column
and centrifuged at 16,0006g for 1 minute. Each column was rinsed
four times with 500 ml IP buffer; proteins were eluted with 30 ml
‘sample buffer’ (Cytosignal) and incubated at room temperature for
15 minutes before centrifugation at 20,0006g for 2 minutes.
Samples were denatured with b-mercaptoethanol (710 mM) and
heat (95uC for 1 minute) before loading onto a 12% SDS
polyacrylamide gel (Invitrogen, CA). Proteins were transferred to
nitrocellulose membranes (Amersham Pharmacia, PA), blocked
with ‘SuperBlock’ buffer (Pierce, IL) for 1 hour, and then probed
with Kv12.2 (1:200) antibody for 1 hour at room temperature.
Secondary antibody chicken-anti-rabbit-HRP (Santa Cruz, CA;
1:5000) was applied for 1 hour at room temperature, and the
membrane was developed with Supersignal ECL (Pierce, IL). The
membranewas then repeatedly strippedwithWesternblot stripping
buffer (Pierce, IL) and probed sequentially with anti-KCNE1
(1:200), anti-KCNE3 (1:200), and finally anti-Kir2.1 (1:200) as a
negative control. Co-immunoprecipitation experiments were per-
formed three times yielding similar results.
For native co-immunoprecipitation experiments whole mouse
brains were homogenized according to the ‘NativePAGE sample
preparation kit’ (Invitrogen) instructions. Briefly, mouse whole
brain (,10 mg) was homogenized in 1 ml of NativePAGE sample
buffer (plus 1% digitonin and a protease inhibitor cocktail) by
sonication on ice (3615 seconds each at ,50% power). The lysate
was centrifuged (20,000 g) for 30-minutes at 4uC, and once
clarified lysate protein concentration was determined by BCA
(Invitrogen) assay. Co-immunoprecipitation experiments were
conducted as above with the following modifications, lysate
(20 ml) was added directly to each respective antibody bound
(KCNE1/KCNE3 or IRK1) protein A/G sepharose column and
left overnight at 4uC. The column was subsequently washed and
proteins were eluted with the NativePAGE sample buffer, 50% of
the eluted protein was directly applied to a ‘second-round co-
immunopreciptiation assay’ with the channel Kv12.2 antibody
bound to the column, and the remaining 50% reserved for direct
gel electrophoresis analysis. G-250 (0.25%) sample additive
(Invitrogen) was added to each protein preparation prior to
loading onto a 4-16% ‘NativePAGE Novex Bis-Tris Gel’
(Invitrogen). Electrophoresis with blue ‘NativePAGE Cathode
Buffer’ (Invitrogen) and ‘NativePAGE Anode Buffer’ both at pH 7
(Invitrogen) was begun at 10 mA at 4uC for 1.5 hours. After
1.5 hours, the cathode buffer was replaced by anode buffer, and
electrophoresis continued for a further 5 hours at 8 mA (120 V).
Proteins were transferred overnight at 4uC in ‘NuPAGE Transfer
Buffer’ (Invitrogen) to a PVDF membrane (Amersham Pharmacia,
Table 2. RT-PCR Xenopus (x) primer sequences.
Gene Sense primer sequence Antisense primer sequence
xKCNE1 59-ATGCCAGGGTTAAACACCACTGCC-39 59-CTAGTTGCTGGGAGAAGAGGGGATATA-39
xKCNE3 59-CAGTTTGATTGGAGAGTGGGATTC-39;5 9-TAGACCCCTGGGGCCTCGTC-39
xKCNE5.1 59-ATGAATTGTAGTAATACTTCTC-39 59-CTAAAGTAAGTTTTCACTTTCAATACT-39
xb-actin 59-AAGGAGACAGTCTGTGTGCGTCCA-39 59-CAACATGATTTCTGCAAGAGCTCC-39
doi:10.1371/journal.pone.0006330.t002
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probed with respective antibodies as above.
Electrophysiology
Macroscopic currents were recorded from oocytes using
standard two-electrode voltage-clamp (CA-1B amplifier (Dagan
Corp., MN)), sampled at 2 KHz and filtered at 1 KHz. Data were
collected using the pCLAMP/Digidata acquisition package (Axon
Instruments, CA), and subsequently analyzed using Clampfit
(Axon instruments, CA) and Origin (OriginLab, MA). Micro-
electrodes contained 3 M KCl and had tip resistances between
0.5–1 MV. Oocytes were continually perfused with extracellular
solution at room temperature containing: 98 mM Na-methane-
sulfonate (MES), 2 mM K-MES, 2 mM CaCl2, 10 mM HEPES,
pH 7.0. The low [Cl
2] of the recording solutions was sufficient to
eliminate contaminating outward native Cl
2 currents. Agar
bridges (1 M NaCl) were used to isolate bath clamp circuitry.
Peak currents were measured at each voltage, and conductance/
voltage (GV) parameters are averages derived from Boltzmann fits
of isochronal tail currents recorded at 260 mV (G=Gmax/
[1+exp(V - V0.5/k)], where V0.5 is the half-maximal activation, and
k is the slope factor). All values are mean6SEM (n$6), statistical
significance was determined by Students t test for unpaired
observations; significance was taken as P,0.05.
Results
Kv12.2 channel currents in Xenopus oocytes are
suppressed by endogenous KCNE1 and KCNE3
Previous studies have demonstrated that KCNE1, KCNE3, and
KCNE5.1 are endogenously expressed in Xenopus oocytes [29]. We
therefore investigated whether these endogenous K
+ channel b-
subunit regulatory proteins modulate heterologously expressed
Kv12.2 channels. RNA interference (siRNA) was firstly utilized to
specificallyknockdown endogenousKCNE1,KCNE3orKCNE5.1
expression. Double-stranded xKCNE-specific siRNA oligos de-
signed by Anantharam et al. (2003) [29] were injected into Xenopus
oocytes to assess their ability to knock down xKCNE mRNA
expression. The band intensity of amplified KCNE1 cDNA from
oocytes injected with xKCNE1 siRNA was almost non-detectable
(Figure 1A, F). Similarly, xKCNE3 and xKCNE5.1 siRNA
significantly reduced KCNE3 and KCNE5.1 cDNA expression.
(Figure 1B, C, F). To ensure the quality and equal cDNA
concentrations between samples, results were normalized with
RT-PCR for Xenopus b-actin cDNA. We also examined whether
xKCNE1 siRNA affected xKCNE3 RNA levels and vice versa.N o
detectable gene knockdown of either KCNE1 or KCNE3 was
observedbytheseexperiments,demonstrating thespecificityofeach
respective siRNA (Figure 1D–F).
We next determined the effect of attenuating endogenous KCNE1,
KCNE3, and KCNE5.1 on Kv12.2 channel currents. Two electrode
voltage clamp recordings were performed 48-hours post injection of
Kv12.2 channels, in the absence or presence of the respective KCNE
siRNA. Kv12.2 channel heterologous expression resulted in a
relatively small voltage-dependent outward current (1.260.11 mA
p e a kc u r r e n ta t8 0 m V ;V 50 -21.960.81 mV, Figure 2A, F–G).
Typical of Kv12.2 channel currents, when the voltage was stepped to
potentials above 20 mV the outward current develops a visible rapidly
inactivating component [2,3]. KCNE1 and KCNE3 siRNAs
significantly increased Kv12.2 currents by ,4.1 fold and ,4.2-fold,
respectively (Figure 2B–C, F; p,0.01). Furthermore the combination
of KCNE1 and KCNE3 siRNAs increased Kv12.2 channel currents
,9-fold (Figure 2D, F, p,0.01), suggesting an additive effect of each
KCNE b-subunit. In contrast, KCNE5.1 siRNA knockdown had no
significant effect on Kv12.2 currents, compared to Kv12.2 cRNA
injected only controls (Figure 2E–F). Analysis of isochronal tail
currents revealed that the voltage for Kv12.2 channel activation (GV)
was not significantlyaffected by either xKCNE1 (V50 22261.14 mV)
or xKCNE3 (V50 22461.32 mV) siRNAs when compared to dH2O
injected controls (V50 221.960.81 mV, Figure 2G). However, the
GV was significantly left shifted by ,20 mV by dual injection of
xKCNE1 and xKCNE3 siRNAs (V50 241.260.8 mV, Figure 2G).
Previous studies have shown that KCNE peptides modulate K
+
channel activation and/or deactivation kinetics; for example, KCNE1
slows activation and deactivation of KCNQ1 [24,25], and KCNE3
slows activation and deactivation of Kv2.1 channels in neurons [30].
Therefore, we repeated the experiments on a non-inactivating mutant
Figure1.KnockdownofendogenousKCNEexpressioninXenopus
oocytes with siRNA. (A–E) RT-PCR of xKCNE1, xKCNE3 and xKCNE5.1
mRNA isolated from Xenopus oocytes injected with dH2O( 2)o rt h e
indicated siRNA (+). RT-PCR for b-actin is shown as a control for
normalization of band intensity. (A–C) siRNAs designed against xKCNE1,
xKCNE3 and xKCNE5.1 all significantly knock down mRNA expression level
of their respective target genes. (D–E) In contrast, siRNA targeted to
xKCNE1 and xKCNE3 do not affect mRNA expression levels of other KCNE
genes. (F) Optical density of cDNA bands relative to b-actin was quantified
using NIH ImageJ. xKCNE1, xKCNE3 and xKCNE5.1 siRNA bands indicted a
,10-fold, ,4-fold, and ,4fold reduction in expression of each respective
gene; control injections did not show a significant reduction. Each
experiment was performed 3 times; values show Mean6SEM, ** p,0.01.
doi:10.1371/journal.pone.0006330.g001
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the P region of the channel [14], to better assess the effect of dual
knockdown of KCNE1 and KCNE3 on Kv12.2 channel kinetics. We
did not find significant changes in either activation or deactivation, but
did observe significant increases in current magnitude and a similar
shift in GV as for the wild-type channel with the dual injection of
xKCNE1 and xKCNE3 siRNAs, indicating that the S464T mutation
did not disrupt the channel interaction with KCNE1 and KCNE3
(data not shown). These findings suggest that KCNE1/KCNE3 b
subunits primarily regulate Kv12.2 channels via control of current
amplitude and activation threshold.
Kv12.2 currents are reduced by over-expression of KCNE1
and KCNE3 in Xenopus oocytes
Consistent with xKCNE siRNA gene knockdown studies, co-
injection of Kv12.2 with mKCNE1 or mKCNE3 cRNA signifi-
cantly reduced Kv12.2 currents.2-fold (from 2.2360.02 mA, V50
222.860.12 mV to 0.960.07 mA, V50 222.562.17 mV, or
0.960.06 mA, V50 220.262.1 mV, respectively) (Figure 2H–I).
Similarly, the co-injection of both mKCNE1 and mKCNE3
cRNA further inhibited Kv12.2 currents (,3-fold; 0.737656
0.1375 mA, V50 221.660.9 mV) (Figure 2H–I). Consistent with
siRNA studies, co-expression of mKCNE5 cRNA did not affect
Kv12.2 currents (data not shown). Injection of KCNE1,
KCNE3, or KCNE5 cRNA alone into oocytes did not generate
currents significantly different to H2O-injected controls in our
protocols (data not shown). Previous studies have demonstrated
that injection of KCNE1 b-subunits into oocytes generates a
small, slowly activating IKs-like current via assembly with
endogenous KCNQ1 [24,25]. We probably did not detect a
significant amount of this current in our experiments because we
used much shorter voltage steps and shorter incubation periods.
Taken together these data suggest that KCNE1 and KCNE3 but
not KCNE5 b-subunits, significantly reduce Kv12.2 channel
currents via a mechanism that has only modest effects on
channel gating. Furthermore these studies suggest that the ability
of KCNE1 and KCNE3 to modulate Kv12.2 channels is
conserved across vertebrate species.
Kv12.2 channel antibody generation
A 100 amino acid section (position 702–801) of the cytoplasmic
C-terminus of mouse Kv12.2 was used to generate a Kv12.2-
specific polyclonal antibody in rabbit. The region was selected for
high predicted antigenicity and lack of conservation with other
Kv12 channels (Figure 3A). Western blot analysis demonstrated
that the Kv12.2 antibody recognized a single band of ,120 KDa
(the predicted size of a Kv12.2 monomer) on a denaturing gel in
lysates from mouse brain and HEK-293 cells transiently
transfected with Kv12.2 (Figure 3B). The Kv12.2 antibody (anti-
Kv12.2) did not recognize specific bands in non-transfected HEK-
293 cell lysates, or in HEK-293 cells transfected with the closely
related Kv12.1 channel, or when excess antigenic peptide was
present to block immunodetection (Figure 3B). The antigenic
peptide also blocked detection of Kv12.2 in mouse brain lysates in
separate experiments (data not shown). The antibody therefore
appeared to be highly specific for Kv12.2 channels as no
immunoreactivity was evident in the above conditions.
Biotinylation assays reveal that KCNE1 and KCNE3 gene
knock-down increases Kv12.2 channel membrane surface
expression
We next investigated the mechanism by which KCNE1 and
KCNE3 attenuated Kv12.2 currents. KCNE subunits have been
proposed to directly affect channel conductance, but recent studies
in HEK-293 cells interestingly revealed that KCNE1 and KCNE2
regulate HERG channel surface expression on the plasma
membrane [31]. We therefore hypothesized that KCNE1 and
KCNE3 are important for Kv12.2 channel trafficking. To
investigate this possibility we biotinylated membrane surface
proteins in Xenopus oocytes injected with Kv12.2 channel cRNA
alone and in combination with KCNE1 and/or KCNE3 siRNA.
Retrieval of the tagged proteins allowed us to compare total and
membrane surface expression of Kv12.2 protein for each case.
Oocytes injected with Kv12.2 cRNA showed just detectable cell
surface expression; whereas the co-injection of KCNE1 and/or
KCNE3 siRNA dramatically increased the amount of biotinylated
Kv12.2 channel plasma membrane expression (all ,3-fold
increase, p,0.01) (Figure 4A, B). The magnitude of this increase
is consistent with our previous observations of Kv12.2 current
increases observed with KCNE1 or KCNE3 siRNA knockdown,
suggesting that this change in surface expression accounts for the
changes in current amplitude. Furthermore, we observed an
additional significant increase in Kv12.2 channel plasma mem-
brane expression with the co-injection of both KCNE1 and
KCNE3 siRNA (,22.7% P,0.05 for KCNE1 alone, and ,20%
P,0.05, for KCNE3 alone, Figure 4A, B). We speculate that this
further increase in channel protein expression is less than expected
based on electrophysiology because of saturation of detection
sensitivity in the ECL-based immunoassay. In comparison,
electrophysiological measurements are linear over a wide range
and therefore likely provide a better quantitative measure for
changes in Kv12.2 surface expression. Kv12.2 channel plasma
membrane expression was not detected in water-injected oocytes
(Figure 4A, B), and importantly the biotinylated membrane
fraction did not appear contaminated with endoplasmic reticulum
(ER) proteins, as the specific ER marker calnexin was not detected
(Figure 4A middle panel). The enrichment of Kv12.2 channel
protein in the biotinylated plasma membrane fraction was
confirmed using b1-integrin as a plasma membrane marker
(Figure 4A, bottom panel).
In addition to determining the effect of KCNE peptides on
Kv12.2 channel plasma membrane surface expression, we assessed
changes in total channel protein expression. Determining the
effects of the KCNE b-subunits on total channel protein were
important as previous studies have shown that KCNE4 and
KCNE5 decreased KCNQ plasma membrane expression by
reducing total channel protein expression [32]. Importantly no
changes were observed in the total amount of the channel protein
following KCNE1 and/or KCNE3 co-injection, when compared
to Kv12.2 channel injected alone (Figure 4C, D). The increase in
Kv12.2 channel expression is therefore specific to the plasma
membrane, and not due to a non-specific increase in total oocyte
Kv12.2 channel protein expression.
In summary we demonstrate that KCNE1 or KCNE3 gene
knockdown significantly increased Kv12.2 channel membrane
expression, and moreover the dual knockdown of both regulatory
b-subunits significantly increased further the channel membrane
fraction. Taken together these studies suggest that endogenous
KCNE1 and KCNE3 are important for the regulation of Kv12.2
trafficking to the plasma membrane and subsequent channel
activation.
KCNE1 and KCNE3 interact with Kv12.2 channels in vivo
Next we questioned whether endogenous KCNE1 and/or
KCNE3 b-subunits interact with neuronal Kv12.2 channels in the
brain by looking for Kv12.2/KCNE protein complexes in vivo.
Mouse brain lysates were immunoprecipitated with the following
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PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6330Figure 2. KCNE1 and KCNE3 inhibit Kv12.2 currents in Xenopus oocytes. (A–E) Current traces recorded from oocytes injected with (A) Kv12.2
cRNA only, or co-injected (B) KCNE1, (C) KCNE3, (D) KCNE1 and KCNE3, or (E) KCNE5.1 siRNAs. Currents were recorded in response to 2 s voltage steps
from 2100 to +80 mV, in 20 mV increments from a holding potential of 2100 mV; tail currents were recorded at 240 mV (protocol in inset). (F) Peak
current-voltage relationships from oocytes injected with Kv12.2 cRNA only (&), or Kv12.2 cRNA plus either KCNE1 (N), KCNE3 (m), KCNE1 and KCNE3
(.), or KCNE5.1 (¤) siRNAs. KCNE1 and KCNE3 siRNAs significantly increase Kv12.2 currents and have an additive effect in combination. (Mean6SEM,
n=12–16, ** p,0.01). (G) Normalized conductance voltage (GV) curves measured from isochronal tail currents for oocytes injected with Kv12.2 cRNA
only (&), and either KCNE1 (N), KCNE3 (m), or KCNE1+KCNE3 (.) siRNA. Lines show Boltzmann fits; parameters are given in the Results. Only dual
injection of xKCNE1 and xKCNE3 siRNAs caused a significant shift in V50. Data are given as Mean6SEM, n=12–16, (** p,0.01). (H) Peak current-
voltage relationships from oocytes injected with Kv12.2 cRNA (&), or Kv12.2 cRNA+mKCNE1 (N), mKCNE3 (m), mKCNE1 and mKCNE3 (.) cRNA
(protocol as in A, Mean6SEM, n=8, * p,0.05, ** p,0.01). Co-injection of Kv12.2 with mKCNE1 and/or mKCNE3 cRNA significantly reduced Kv12.2
currents. (I) GV curves from isochronal tail currents recorded from oocytes injected with Kv12.2 cRNA (&), or Kv12.2 and either mKCNE1 (N), mKCNE3
(m), and mKCNE1 and mKCNE3 (.) cRNA. Boltzmann fits (lines) revealed that the voltage-dependence of Kv12.2 activation was not significantly
affected by overexpression of KCNE1 and KCNE3. V50 values are given in the Results (n=8).
doi:10.1371/journal.pone.0006330.g002
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immunoblots were probed with anti-Kv12.2. Immunoblot indi-
cated that both KCNE1 and KCNE3 interact directly in vivo with
Kv12.2 channels (Figure 5A, top panel). The specificity of this
interaction was demonstrated using anti-Kir2.1 antibody as a
negative control; Kir2.1 is an inwardly rectifying potassium
channel that is highly expressed in the brain [33], and does not
interact with KCNE1 [34]. In our experiments, Kir2.1 immuno-
reactivity was evident in mouse brain (data not shown); however it
did not demonstrate significant binding to KCNE1, KCNE3 or
Kv12.2 channels (Figure 5A). To further confirm the co-
immunoprecipitation results we performed reciprocal experiments
using anti-Kv12.2 as the ‘pull-down’ antibody; the blots were
probed with either anti-KCNE1 or anti-KCNE3. Consistent with
the KCNE1 and KCNE3 co-immunoprecipitation data, anti-
Kv12.2 ‘pull-down’ experiments revealed that both KCNE1 and
KCNE3 immunoprecipitate with Kv12.2 channels (Figure 5A
middle and bottom panels, respectively).
To further characterize the KCNE1/KCNE3 b-subunit
interaction with Kv12.2 channels we performed a two-step co-
immunoprecipitation assay under native protein conditions. The
main aim for conducting these additional co-immunoprecipitation
experiments was to determine whether KCNE1 and KCNE3 b-
subunits simultaneously interact with individual tetrameric Kv12.2
channels in neurons. Consistent with previous data, under native
conditions the tetrameric Kv12.2 channel immunoprecipitates
Figure 3. Characterization of the Kv12.2 channel antibody. (A) Alignment of a 100 amino acid section, 702–801 of the cytoplasmic C-terminus
of mouse Kv12.2 used to generate a Kv12.2-specific polyclonal antibody in rabbit to Kv12.1. The homologous region of Kv12.3 (not shown), is most
similar to Kv12.1. Amino acid identities are shaded and numbers indicate amino acid position in Kv12.2. The cartoon depicts a Kv12.2 subunit with 6
transmembrane domains (S1–S6), a Per-Arnt-Sim (PAS) motif and a putative cyclic nucleotide binding motif (cNBD). Gray scale coding indicates the
level of amino acid identity shared between Kv12.2 and other Kv12 channels in each region of the channel. (B) Top panel, Western blot analysis
demonstrates that the Kv12.2 antibody (anti-Kv12.2) recognizes a single band of ,120 KD (the predicted size of a Kv12.2 channel monomer) from
mouse brain and HEK-293 cells transiently transfected with mKv12.2 channel cDNA (HEK-293+Kv12.2). Anti-Kv12.2 did not recognize specific bands in
non-transfected HEK-293 cell lysates (HEK-293), in HEK-293 cells transfected with the closely related Kv12.1 channel (HEK-293+Kv12.1), or when excess
antigenic control peptide (CP) was present to block immunodetection (HEK-293+Kv12.2+CP). Bottom panel, anti-b-actin demonstrates equal protein
loading for each condition. These experiments were repeated 4 times yielding similar results.
doi:10.1371/journal.pone.0006330.g003
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this interaction was assessed using the anti-Kir2.1 antibody as a
negative control (Figure 5B). The size of the Kv12.2 channel
complex was ,500 Kd, which is consistent with a tetrameric pore
structure and allows for small associated proteins such as KCNE1
and KCNE3. The migration of KCNE1 and KCNE3 with this
large Kv12.2 channel complex is strong additional proof for
specific interaction of these proteins in vivo and importantly shows
that channel structure is maintained under the conditions we used
for co-immunoprecipitation assays. This allowed us to ask whether
KCNE1 and KCNE3 simultaneously interact with individual
tetrameric Kv12.2 channels, since it is believed that multiple, and
most likely two, KCNE subunits associate with each tetrameric
potassium channel [35,36]. Since KCNE1 and KCNE3 do not
interact directly, such a scenario could only be detected if
tetrameric channel structure is maintained during immunoprecip-
itation assays. The relatively small size of the KCNE1 and
KCNE3 subunits, 14 kDa and 36 kDa respectively, makes it
impossible to accurately determine the stoichiometry of KCNE/
Kv12.2 interactions based on the Kv12.2 channel complex size.
Therefore, to determine whether both KCNE1 and KCNE3 b-
subunits can interact with tetrameric Kv12.2 channels simulta-
neously, we conducted a ‘second- round’ co-immunoprecipitation
experiment, whereby the proteins from the ‘first-round’ KCNE1
or KCNE3 ‘pull-down’ were subsequently subjected to pull-down
by anti-Kv12.2. Blots were then probed with either anti-KCNE1
or anti-KCNE3. Following the ‘second-round’ co-immunoprecip-
itation with anti-Kv12.2, KCNE3 protein could be detected in
samples where anti-KCNE1 was used for the ‘first-round’ pull-
down. In addition the reciprocal interaction occurred when anti-
Figure 4. KCNE1 and KCNE3 reduce membrane surface expression of Kv12.2 channels. (A) Blots of the biotinylated plasma membrane
fraction of proteins from Xenopus oocytes injected with Kv12.2 cRNA alone or in combination with KCNE1 and/or KCNE3 siRNA subjected to
membrane surface biotinylation. Top panel, Detection of Kv12.2 channel protein with anti-Kv12.2. Xenopus oocytes injected with Kv12.2 cRNA showed
just detectable membrane surface expression; whereas the co-injection of KCNE1 and/or KCNE3 siRNA dramatically increased Kv12.2 channel plasma
membrane expression. Kv12.2 was not detected in oocytes injected with dH2O (negative control), and was robustly detected in mouse whole brain
lysate (positive control). An endoplasmic reticulum (ER) marker (calnexin, middle panel), and a cell membrane marker (b1-integrin, bottom panel), were
used as a negative and positive controls, respectively, to show specific isolation of the plasma membrane protein fraction and to confirm equal
protein loading. (B) The optical density of each Kv12.2 protein band was quantified using NIH ImageJ and normalized to density of b1-integrin for
comparison; both xKCNE1 or xKCNE3 siRNA increased Kv12.2 channel membrane expression.3-fold (Mean6SEM, n=4, ** p,0.01). Furthermore, the
combination KCNE1 and KCNE3 siRNA increased surface Kv12.2 expression ,20% further than either siRNA alone (n=4, * p,0.05). (C) Blots showing
total protein expression from Xenopus oocytes injected as in A. Top panel, Kv12.2 channel total expression was not detected in dH2O-injected oocytes,
and did not increase when Kv12.2 was injected with siRNA for KCNE1 and/or KCNE3. Bottom panel, b-actin was used to confirm equal protein loading
for each condition assessed. (D) The optical density of each Kv12.2 protein band was quantified using NIH ImageJ and normalized to b-actin; xKCNE1,
xKCNE3 or KCNE1 and KCNE3 siRNA did not significantly affect total Kv12.2 channel expression (Mean6SEM, n=4).
doi:10.1371/journal.pone.0006330.g004
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and the final blot was probed for presence of KCNE1 (Figure 5C,
D). These two-step co-immunoprecipitation experiments were
repeated 3 times with similar results. The results suggest that
KCNE1 and KCNE3 b subunits form tripartite channel
complexes with Kv12.2 in vivo.
Discussion
We demonstrate here that the K
+ channel b-subunits KCNE1 and
KCNE3 regulate trafficking and activation of Kv12.2. This is the first
evidence that KCNE subunits associate with Kv12 family potassium
c h a n n e l s .F u r t h e r m o r e ,w es h o wb yn ative co-immunoprecipitation
experiments that both b-subunits, KCNE1 and KCNE3, simulta-
neously interact with tetrameric Kv12.2 channels in vivo;s u g g e s t i n g
the existence of a native channel tripartite complex (Kv12.2-KCNE1-
KCNE3). As Kv12.2 channels are highly expressed in several
important brain regions, including the hippocampus, amygdala and
cerebral cortex [5,8], we predictthat in vivoassociation of KCNE1 and
KCNE3 with Kv12.2 channels has considerable significance to the
modulation of neuronal excitability. The specific localization of
KCNEs in the brain has not been carefully defined; however northern
blot analysis in human brain has demonstrated that KCNE3 is
expressed in the hippocampus, cerebellum, thalamus, hypothalamus
and cerebral cortex [30] and has therefore has specific overlap with
areas high in Kv12.2 channel expression [8]. It is now well established
that KCNQ1 channels assemble with KCNE b-subunits for correct
physiological function; mutations that disrupt this complex formation
result in congenital deafness and inherited cardiac arrhythmias
[10,37,38]. Interestingly studies in the heart have shown that the
Figure 5. Kv12.2 channels simultaneously associate with KCNE1 and KCNE3 b-subunits in vivo. (A) Mouse brain lysates (MB) were
immunoprecipitated (IP) with anti-KCNE1, anti-KCNE3, anti-Kv12.2, or anti-Kir2.1 and were then subjected to SDS-PAGE and Western Blot analysis.
Whole mouse brain lysate (MB) and proteins precipitated with unconjugated beads (AG only) are shown as positive and negative controls,
respectively. Proteins used for IP are indicated at the top, proteins detected in Western blot (IB) are indicated at the left. Top panel, IB with anti-Kv12.2
indicates that both KCNE1 and KCNE3 interact in vivo with Kv12.2 channels. Middle panel, IB was stripped and re-probed with anti-KCNE1. KCNE1
immunoprecipitates with Kv12.2 but not KCNE3. Bottom panel, IB was then re-stripped and re-probed with anti-KCNE3. KCNE3 immunoprecipitates
with Kv12.2 but does not interact with KCNE1. Controls show little or no IP of Kv12.2, KCNE1 or KCNE3 with anti-Kir2.1 or unconjugated beads. (B–D)
Two-step co-immunoprecipitation assays run under native protein conditions. The Kv12.2 channel complex labeled under native conditions was
,500 Kd, consistent with a channel tetramer. (B) Kv12.2 channels were immunoprecipitated first with anti-KCNE1 or anti-KCNE3 in these native
protein conditions. Specificity was assessed using the anti-Kir2.1 antibody and unconjugated beads as negative controls. Proteins
immunoprecipitated in this first IP were subjected to a second IP using anti-Kv12.2. (C) Anti-KCNE1 detected the Kv12.2 tetramer complex after
the second IP regardless of whether anti-KCNE1 or anti-KCNE3 was used for the first IP. (D) Similarly, anti-KCNE3 detected the Kv12.2 complex after
the second IP with anti-Kv12.2 even if anti-KCNE1 was used for the first IP. These results can be explained if KCNE1 and KCNE3 simultaneously interact
with individual Kv12.2 channels. Denatured mouse brain lysate was loaded into the first lane, to confirm the established size of the respective KCNE b-
subunit. Note that some KCNE1 has dissociated from the channel complex in the KCNE1 lane of (C).
doi:10.1371/journal.pone.0006330.g005
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suggesting that a balance in the variety of KCNE b-subunits may be
required to physiologically regulate K
+ channels [39]. Our data
suggest that a similar regulatory mechanism may exist in the brain.
Possible roles for KCNE b subunits in the regulation of other
neuronal K
+ channels have been proposed. Furthermore the
mRNA transcripts for all five KCNE b-subunits have been
detected in tissue from rodent brain [10]. McCrossan et al. (2003)
[14] have demonstrated that Kv2.1 and Kv3.1 immunoprecipitate
from rat brain membranes with anti-KCNE3 antibodies. Both
KCNE1 and KCNE3 reduced the current density of Kv2.1 and
Kv3.1 channels in heterologous expression systems, the mecha-
nism was shown to be via a direct effect on gating kinetics, and not
regulating plasma membrane expression [14], as we find for
Kv12.2 channels. More recent studies have demonstrated that
heterologously expressed Kv4.3 channels, which are activated
during neuronal excitation and are believed to have a role in spike
repolarization and frequency, are dramatically inhibited by
KCNE3 b-subunits by effects on both activation kinetics and
current amplitude [40]. We show here for the first time that
KCNE subunits may also regulate the activity of a K
+ channel
believed to significantly contribute to neuronal resting potential.
Further in vivo studies are required to characterize and determine
the trafficking dynamics and physiological significance of this
Kv12.2 -KCNE1-KCNE3 channel regulatory tripartite complex.
The most pronounced effect of KCNE1 and KCNE3 on Kv12.2
channels is on the regulation of plasma membrane expression. We
demonstrate that KCNE1 and/or KCNE3 b-subunits did not affect
overallKv12.2channeltotalprotein expression. Previous studieshave
suggested a similar role of the KCNE b-subunits in K
+ channel
regulation. Nicolas et al. (2001) demonstrated in KCNE1 knock-out
mice, that KCNQ1 channels do not traffic to the apical membranes
of vestibular dark cells, where they would normally be found in wild
type cells [41], suggesting that KCNE1 b-subunits chaperone
KCNQ1 to the membrane surface or alternatively stabilize
membrane expression. Interestingly KCNE3 has been shown
previously to inhibit hERG channels, suggesting either the formation
of a non-functional channel, or one that fails to reach the plasma
membrane [29]. Similarly in our study Kv12.2channel currents were
increased by the knockdown of endogenous KCNE1 and/or KCNE3
b-subunits, and attenuated by the over-expression. Our results clearly
show that increased Kv12.2 current following knockdown of KCNE1
and KCNE3 occurs primarily through enhanced surface expression.
We assume Kv12.2 current reductions induced by KCNE1 and
KCNE3 overexpression result from reduced surface expression,
although we did not definitively determine the mechanism using the
surface biotinylation assay. KCNQ1-KCNE1 assembly is chaperone
mediated, suggesting that these proteins first associate in either the
ER or cis-Golgi; as KCNQ1 channels assemble early in the secretory
pathway [42]. This suggests the possibility that KCNE subunits could
affect membrane trafficking of K
+ channels by control of retention in
or export from the ER. Interes t i n g l yar e c e n ts t u d yb yX uetal. (2009),
demonstrated that KCNQ1-KCNE1 complexes but not homomeric
KCNQ1 channels undergo clathrin- and dynamin 2-dependent
internalization; redefining KCNE1 as an endocytic chaperone for
KCNQ1 [43]. Further studies are required to define whether
KCNE1 and KCNE3 determine membrane surface expression of
Kv12.2 through control of export to the plasma membrane,
promotion of endocytic recycling, or a combination of both
mechanisms.
The subunit composition of KCNE-containing channel com-
plexes can greatly influence channel function [10], and it is
therefore important to understand the stoichiometry of native
channel complexes. Here we demonstrate in vivo that both KCNE1
and KCNE3 appear to simultaneously interact with individual
Kv12.2 channel tetramers. Remixing of subunits during the co-IP
assays to produce these results remains a possibility, but is
extremely unlikely due to high dilution factors and removal of the
proteins from the membrane context. Recent in vitro investigations
with K
+ channels have proposed that two KCNE peptides interact
with the channel tetramer [35,36]. Several K
+ channels, including
KCNQ1, hERG and Kv2.1 have been shown to interact with
multiple distinct KCNE peptides in vitro [15,16,20,24,25,44]. One
recent study even demonstrated that KCNE1 and KCNE4 can
simultaneously interact with KCNQ1 channels in COS-M6 cells
[45]. However, the question of whether individual channels may
contain multiple distinct KCNE proteins in vivo has never been
examined prior to this study. We present evidence demonstrating
that a significant portion of Kv12.2 channels contain both KCNE1
and KCNE3 b subunits in vivo. However, we cannot rule out the
possibility that Kv12.2 channels also complex separately with
either KCNE1 or KCNE3 in the brain.
We observed an additive increase over the effect of either siRNA
alone with both KCNE1 and KCNE3 knockdown on Kv12.2
channel plasma membrane expression. Several mechanisms may
have meditated this additive effect. Firstly, it is possible that
KCNE1 and KCNE3 have independent effects on Kv12.2 traf-
ficking and are not able to substitute for each other. In this case,
both subunits would have to be present for maximal inhibition of
Kv12.2 channel expression on the membrane. Alternatively, it may
be the case that KCNE1 and KCNE3 do have redundant effects on
trafficking in Xenopus oocytes, and that removal of either may simply
reduce the number of channels that contain a KCNE subunit. In
support of this view, KCNE subunits have similar structures [10]
and are thus likely to interact with K
+ channel a-subunits in
overlapping binding sites. It would be interesting to determine
whether all or only a subset of these KCNE binding sites must be
occupied to affect trafficking of Kv12.2 channels. The demonstra-
tion of heterologous assembly between a K
+ channel (Kv12.2) and
KCNE family regulatory b-subunits, suggests that the promiscuity
of K
+ channel/KCNE interactions observed in vitro may reflect
complexity in the stoichiometry of channels formed in vivo.
In summary, this study demonstrates for the first time that
KCNE1 and KCNE3 b-subunits form a tripartite complex with
Kv12.2 channels in the brain; and furthermore suggests that
regulation of membrane surface expression, and subsequent
channel activation as a function of this association.
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